Tracon Pharmaceuticals News

Tracon Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

SECAug 14 05:03 · Announcements

TRACON Pharmaceuticals Initiates Wind-Down and Leadership Changes

TipRanksJul 31 05:19

Express News | TRACON Pharmaceuticals Inc - Board Appointed Craig R. Jalbert as President, CEO

BreakingsJul 31 04:58

Express News | TRACON Pharmaceuticals Inc - Scott B. Brown, CFO and Secretary Will Cease Serving as Officer of Co Effective July 31

BreakingsJul 31 04:58

Express News | TRACON Pharmaceuticals Inc - Charles P. Theuer Tendered His Resignation as Co's President and CEO

BreakingsJul 31 04:57

Express News | TRACON Pharmaceuticals Inc - Board Approved Dissolution and Liquidation of Company Pursuant to a Plan of Dissolution

BreakingsJul 31 04:56

Express News | TRACON Pharmaceuticals Inc - Expects to Incur One-Time Charges and Cash Expenditures Associated With Workforce Reduction of Approximately $1.7 Mln

BreakingsJul 31 04:56

Express News | TRACON Pharmaceuticals- Approved Reduction in Force of Substantially All of Its Employees in Connection With Planned Wind Down of Co's Operations

BreakingsJul 31 04:55

Express News | TRACON Pharmaceuticals Inc - Announces It Will Wind Down Operations

BreakingsJul 31 04:45

Sector Update: Health Care Stocks Slipping in Afternoon Trading

MT NewswiresJul 2 02:05

Sector Update: Health Care

MT NewswiresJul 2 01:52

HC Wainwright & Co. Downgrades TRACON Pharma to Neutral

BenzingaJul 2 01:43

TRACON Pharma Analyst Ratings

BenzingaJul 2 01:41

H.C. Wainwright Downgrades Tracon Pharmaceuticals(TCON.US) to Hold Rating

H.C. Wainwright analyst Edward White downgrades $Tracon Pharmaceuticals(TCON.US)$ to a hold rating.According to TipRanks data, the analyst has a success rate of 28.9% and a total average return of -16

Futu NewsJul 2 00:31 · Ratings

Express News | TRACON Pharmaceuticals, Inc. : H.c. Wainwright Cuts to Neutral From Buy

BreakingsJul 1 23:44

Tracon to Explore Strategic Alternatives After Trial Misses Target

MT NewswiresJul 1 23:17

TRACON Ends Development of Envafolimab, Exploring Strategic Options

Seeking AlphaJul 1 22:33

Express News | TRACON Pharmaceuticals Inc - to Reduce Cash Burn Immediately

BreakingsJul 1 21:00

Express News | TRACON Pharmaceuticals Inc - Envasarc Trial Orr Is 5%, Does Not Meet 11% Endpoint

BreakingsJul 1 21:00

Express News | TRACON Pharmaceuticals Inc - to Focus on Exploring Strategic Alternatives

BreakingsJul 1 21:00